[Therapeutic trend in acne associated with the menstrual cycle].
D000152:Acne Vulgaris / Q000188:drug therapy* / Q000209:etiology; D000328:Adult; D000726:Androgen Antagonists / Q000627:therapeutic use*; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D003534:Cyproterone / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016912:Levonorgestrel; D008599:Menstruation Disturbances / Q000150:complications*; D009644:Norgestrel / Q000627:therapeutic use*
D000726:Androgen Antagonists; D003277:Contraceptives, Oral, Combined; D009644:Norgestrel; D004997:Ethinyl Estradiol; D016912:Levonorgestrel; D003534:Cyproterone
Indirizzo terapeutico nelle affezioni acneiche associate a disturbi del ciclo mestruale.